Evidence map›Paper›PMID 32583136›Full record

ArticleJournal of autism and developmental disorders2021

Evaluation of Appetite-Regulating Hormones ın Young Children with Autism Spectrum Disorder.

Çağla Çelikkol Sadıç, Ayhan Bilgiç, İbrahim Kılınç, Mehmet Burhan Oflaz, Tamer Baysal

Abstract readEvaluation Study
PubMed Publisher
In one paragraph

Article in Journal of autism and developmental disorders, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.7field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Çağla Çelikkol SadıçDepartment of Child and Adolescent Psychiatry, Necmettin Erbakan University Meram School of Medicine, Konya, Turkey. dr.cagla90@gmail.com.ORCID http://orcid.org/0000-0001-6153-301X
Ayhan BilgiçDepartment of Child and Adolescent Psychiatry, Necmettin Erbakan University Meram School of Medicine, Konya, Turkey.
İbrahim KılınçDepartment of Biochemistry, Necmettin Erbakan University Meram School of Medicine, Konya, Turkey.
Mehmet Burhan OflazDepartment of Child Cardiology, Necmettin Erbakan University Meram School of Medicine, Konya, Turkey.
Tamer BaysalDepartment of Child Cardiology, Necmettin Erbakan University Meram School of Medicine, Konya, Turkey.
Necmettin Erbakan University · TR

Funding

the Scientific Research Project Coordination Unit of Necmettin Erbakan University 18151802
6 · The paper itself

Abstract

This study aimed to investigate the role of leptin, ghrelin, neuropeptide Y, and nesfatin-1 in young children with autism spectrum disorder (ASD). A total of 44 children with ASD and 44 healthy controls aged 18-60 months were included. Plasma levels of hormones were measured using commercial enzyme-linked immunosorbent assay kits. Plasma leptin and ghrelin levels were significantly higher in the ASD group than in the control group. However, no significant difference for plasma neuropeptide Y and nesfatin-1 levels was detected between the groups. No relation was found between the severity of ASD symptoms, severity of eating problems, and plasma levels of hormones. Leptin and ghrelin may play a potential role in the pathogenesis of ASD.

Indexed as

AppetiteAutism Spectrum DisorderBiomarkersChild, PreschoolFemaleGhrelinHumansInfantLeptinMaleNeuropeptide YNucleobindinsBiomarkersGhrelinLeptinNeuropeptide YNUCB2 protein, humanNucleobindinsAutismEarly childhoodGhrelinLeptinNesfatin-1Neuropeptide Y

Identifiers

PMID32583136
OpenAlexW3037614343

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.